Integra LifeSciences Holdings Corp. (IART) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Sanmina Corp.

Globus Medical, Inc.

Envista Holdings Corp.

Lantheus Holdings, Inc.

Merit Medical Systems, Inc.

Glaukos Corp.

Sotera Health Co.

Haemonetics Corp.

Neogen Corp.

Integra LifeSciences Holdings Corp.

Inari Medical, Inc.

Why is Integra LifeSciences Holdings Corp. ?

Poor long term growth as Operating profit has grown by an annual rate -5.42% of over the last 5 years

The company has declared Negative results for the last 3 consecutive quarters

NET PROFIT(HY) At USD 8.56 MM has Grown at -81.1%
OPERATING CASH FLOW(Y) Lowest at USD 71.45 MM
INTEREST(HY) At USD 55.64 MM has Grown at 31.56%

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 52.24%, its profits have risen by 9.4% ; the PEG ratio of the company is 0.8

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Integra LifeSciences Holdings Corp. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Integra LifeSciences Holdings Corp.

49.79%

-0.68

62.50%

S&P 500

20.78%

1.67

13.28%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

3.57%

EBIT Growth (5y)

-5.42%

EBIT to Interest (avg)

5.10

Debt to EBITDA (avg)

3.74

Net Debt to Equity (avg)

1.04

Sales to Capital Employed (avg)

0.50

Tax Ratio

32.73%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

7.88%

ROE (avg)

10.40%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.73

EV to EBIT

14.66

EV to EBITDA

7.57

EV to Capital Employed

0.89

EV to Sales

1.45

PEG Ratio

0.83

Dividend Yield

ROCE (Latest)

6.10%

ROE (Latest)

10.43%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bearish

Mildly Bullish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company

PRE-TAX PROFIT(Q)

At USD 27.13 MM has Grown at 497.95%

NET PROFIT(Q)

At USD 24.92 MM has Grown at 1,301.16%

RAW MATERIAL COST(Y)

Fallen by -3.63% (YoY

-19What is not working for the Company

NET PROFIT(HY)

At USD 8.56 MM has Grown at -81.1%

OPERATING CASH FLOW(Y)

Lowest at USD 71.45 MM

INTEREST(HY)

At USD 55.64 MM has Grown at 31.56%

DEBT-EQUITY RATIO (HY)

Highest at 170.18 %

CASH AND EQV(HY)

Lowest at USD 529.24 MM

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.57 times

Here's what is working for Integra LifeSciences Holdings Corp.

Pre-Tax Profit

At USD 27.13 MM has Grown at 497.95%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (USD MM)

Net Profit

At USD 24.92 MM has Grown at 1,301.16%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (USD MM)

Raw Material Cost

Fallen by -3.63% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation

Highest at USD 38.43 MM

in the last five periods

MOJO Watch

The expenditure on assets done by the company may have gone into operation

Depreciation (USD MM)

Here's what is not working for Integra LifeSciences Holdings Corp.

Operating Cash Flow

Lowest at USD 71.45 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Interest

At USD 55.64 MM has Grown at 31.56%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Debt-Equity Ratio

Highest at 170.18 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Cash and Eqv

Lowest at USD 529.24 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Inventory Turnover Ratio

Lowest at 1.57 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio